|
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer
|
journal
|
July 2010 |
|
Nucleoside transport in rat erythrocytes: two components with differences in sensitivity to inhibition by nitrobenzylthioinosine andp-chloromercuriphenyl sulfonate
|
journal
|
February 1986 |
|
Functional characterization of human equilibrative nucleoside transporter 1
|
journal
|
December 2016 |
|
Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep
|
journal
|
February 2004 |
|
The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29
|
journal
|
April 2013 |
|
Fluorescence-Detection Size-Exclusion Chromatography for Precrystallization Screening of Integral Membrane Proteins
|
journal
|
April 2006 |
|
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?
|
journal
|
June 2016 |
|
Nucleoside transporters: molecular biology and implications for therapeutic development
|
journal
|
May 1999 |
|
Synthesis, Flow Cytometric Evaluation, and Identification of Highly Potent Dipyridamole Analogues as Equilibrative Nucleoside Transporter 1 Inhibitors
|
journal
|
August 2007 |
|
Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 Å
|
journal
|
March 2012 |
|
X-ray structure of dopamine transporter elucidates antidepressant mechanism
|
journal
|
September 2013 |
|
Crystal structure of the human glucose transporter GLUT1
|
journal
|
May 2014 |
|
X-ray structures and mechanism of the human serotonin transporter
|
journal
|
April 2016 |
|
Visualizing multistep elevator-like transitions of a nucleoside transporter
|
journal
|
April 2017 |
|
The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference
|
journal
|
July 2004 |
|
Understanding transport by the major facilitator superfamily (MFS): structures pave the way
|
journal
|
January 2016 |
|
Serotonin transporter–ibogaine complexes illuminate mechanisms of inhibition and transport
|
journal
|
April 2019 |
|
Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1
|
journal
|
May 2004 |
|
Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity
|
journal
|
August 2008 |
|
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
|
journal
|
January 2009 |
|
Dipyridamole
|
journal
|
May 1987 |
|
Lipidic cubic phases: A novel concept for the crystallization of membrane proteins
|
journal
|
December 1996 |
|
Mutation of Residue 33 of Human Equilibrative Nucleoside Transporters 1 and 2 Alters Sensitivity to Inhibition of Transport by Dilazep and Dipyridamole
|
journal
|
October 2001 |
|
Topology of a Human Equilibrative, Nitrobenzylthioinosine (NBMPR)-sensitive Nucleoside Transporter (hENT1) Implicated in the Cellular Uptake of Adenosine and Anti-cancer Drugs
|
journal
|
October 2001 |
|
Residues 334 and 338 in Transmembrane Segment 8 of Human Equilibrative Nucleoside Transporter 1 Are Important Determinants of Inhibitor Sensitivity, Protein Folding, and Catalytic Turnover
|
journal
|
March 2007 |
|
Equilibrative nucleoside transporters—A review
|
journal
|
October 2016 |
|
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
|
journal
|
December 2013 |
|
Substructure solution with SHELXD
|
journal
|
September 2002 |
|
XDS
|
journal
|
January 2010 |
|
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM
|
journal
|
March 2011 |
|
REFMAC 5 for the refinement of macromolecular crystal structures
|
journal
|
March 2011 |
|
Experimental phasing for structure determination using membrane-protein crystals grown by the lipid cubic phase method
|
journal
|
January 2015 |
|
Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites
|
journal
|
March 1982 |
|
Residue 33 of Human Equilibrative Nucleoside Transporter 2 Is a Functionally Important Component of Both the Dipyridamole and Nucleoside Binding Sites
|
journal
|
January 2005 |
|
Residues Met89 and Ser160 in the Human Equilibrative Nucleoside Transporter 1 Affect Its Affinity for Adenosine, Guanosine, S 6 -(4-Nitrobenzyl)-mercaptopurine Riboside, and Dipyridamole
|
journal
|
November 2004 |
|
Structure and Mechanism of the Lactose Permease of Escherichia coli
|
journal
|
August 2003 |
|
The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma
|
journal
|
October 2004 |
|
Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma
|
journal
|
April 2009 |
|
The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters
|
journal
|
September 2015 |
|
Interdependence of Gemcitabine Treatment, Transporter Expression, and Resistance in Human Pancreatic Carcinoma Cells
|
journal
|
September 2010 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
|
text
|
January 2010 |
|
Nucleoside Transporter Proteins
|
journal
|
October 2009 |
|
Molecular predictors of gemcitabine response in pancreatic cancer
|
journal
|
January 2011 |
|
Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters
|
journal
|
July 2014 |
|
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer
|
journal
|
July 2010 |
|
Energy coupling mechanisms of MFS transporters: Energy Coupling Mechanisms of MFS Transporters
|
journal
|
September 2015 |
|
Nucleoside transport in rat erythrocytes: two components with differences in sensitivity to inhibition by nitrobenzylthioinosine andp-chloromercuriphenyl sulfonate
|
journal
|
February 1986 |
|
Functional characterization of human equilibrative nucleoside transporter 1
|
journal
|
December 2016 |
|
Adenosine, adenosine receptors and myocardial protection An updated overview
|
journal
|
October 2001 |
|
Nucleoside transporters: molecular biology and implications for therapeutic development
|
journal
|
May 1999 |
|
Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep
|
journal
|
February 2004 |
|
CoMFA and CoMSIA 3D-QSAR studies on S6-(4-nitrobenzyl)mercaptopurine riboside (NBMPR) analogs as inhibitors of human equilibrative nucleoside transporter 1 (hENT1)
|
journal
|
January 2009 |
|
The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29
|
journal
|
April 2013 |
|
Fluorescence-Detection Size-Exclusion Chromatography for Precrystallization Screening of Integral Membrane Proteins
|
journal
|
April 2006 |
|
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?
|
journal
|
June 2016 |
|
Synthesis, Flow Cytometric Evaluation, and Identification of Highly Potent Dipyridamole Analogues as Equilibrative Nucleoside Transporter 1 Inhibitors
|
journal
|
August 2007 |
|
X-ray structures of LeuT in substrate-free outward-open and apo inward-open states
|
journal
|
January 2012 |
|
Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 Å
|
journal
|
March 2012 |
|
X-ray structure of dopamine transporter elucidates antidepressant mechanism
|
journal
|
September 2013 |
|
Crystal structure of the human glucose transporter GLUT1
|
journal
|
May 2014 |
|
Molecular basis of ligand recognition and transport by glucose transporters
|
journal
|
July 2015 |
|
Structure and mechanism of the mammalian fructose transporter GLUT5
|
journal
|
September 2015 |
|
X-ray structures and mechanism of the human serotonin transporter
|
journal
|
April 2016 |
|
Visualizing multistep elevator-like transitions of a nucleoside transporter
|
journal
|
April 2017 |
|
Cloning of a human nucleoside transporter implicated in the Cellular uptake of adenosine and chemotherapeutic drugs
|
journal
|
January 1997 |
|
The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference
|
journal
|
July 2004 |
|
Screening and large-scale expression of membrane proteins in mammalian cells for structural studies
|
journal
|
October 2014 |
|
Understanding transport by the major facilitator superfamily (MFS): structures pave the way
|
journal
|
January 2016 |
|
Rapamycin-inspired macrocycles with new target specificity
|
journal
|
December 2018 |
|
Role of cysteine 416 in N-ethylmaleimide sensitivity of human equilibrative nucleoside transporter 1 (hENT1)
|
journal
|
October 2018 |
|
Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity
|
journal
|
August 2008 |
|
Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1
|
journal
|
May 2004 |
|
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
|
journal
|
January 2009 |
|
Dipyridamole
|
journal
|
May 1987 |
|
Lipidic cubic phases: A novel concept for the crystallization of membrane proteins
|
journal
|
December 1996 |
|
Mutation of Residue 33 of Human Equilibrative Nucleoside Transporters 1 and 2 Alters Sensitivity to Inhibition of Transport by Dilazep and Dipyridamole
|
journal
|
October 2001 |
|
Topology of a Human Equilibrative, Nitrobenzylthioinosine (NBMPR)-sensitive Nucleoside Transporter (hENT1) Implicated in the Cellular Uptake of Adenosine and Anti-cancer Drugs
|
journal
|
October 2001 |
|
Functional Analysis of an Inosine-Guanosine Transporter from Leishmania donovani : THE ROLE OF CONSERVED RESIDUES, ASPARTATE 389 AND ARGININE 393
|
journal
|
June 2003 |
|
Identification and Mutational Analysis of Amino Acid Residues Involved in Dipyridamole Interactions with Human and Caenorhabditis elegans Equilibrative Nucleoside Transporters
|
journal
|
January 2005 |
|
Residues 334 and 338 in Transmembrane Segment 8 of Human Equilibrative Nucleoside Transporter 1 Are Important Determinants of Inhibitor Sensitivity, Protein Folding, and Catalytic Turnover
|
journal
|
March 2007 |
|
Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins
|
journal
|
August 2008 |
|
Equilibrative nucleoside transporters—A review
|
journal
|
October 2016 |
|
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
|
journal
|
December 2013 |
|
Substructure solution with SHELXD
|
journal
|
September 2002 |
|
XDS
|
journal
|
January 2010 |
|
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM
|
journal
|
March 2011 |
|
REFMAC 5 for the refinement of macromolecular crystal structures
|
journal
|
March 2011 |
|
Experimental phasing for structure determination using membrane-protein crystals grown by the lipid cubic phase method
|
journal
|
January 2015 |
|
Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites
|
journal
|
March 1982 |
|
Residue 33 of Human Equilibrative Nucleoside Transporter 2 Is a Functionally Important Component of Both the Dipyridamole and Nucleoside Binding Sites
|
journal
|
January 2005 |
|
Residues Met89 and Ser160 in the Human Equilibrative Nucleoside Transporter 1 Affect Its Affinity for Adenosine, Guanosine, S 6 -(4-Nitrobenzyl)-mercaptopurine Riboside, and Dipyridamole
|
journal
|
November 2004 |
|
Structure and Mechanism of the Lactose Permease of Escherichia coli
|
journal
|
August 2003 |
|
A Competitive Inhibitor Traps LeuT in an Open-to-Out Conformation
|
journal
|
December 2008 |
|
The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma
|
journal
|
October 2004 |
|
Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma
|
journal
|
April 2009 |
|
The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters
|
journal
|
September 2015 |
|
Interdependence of Gemcitabine Treatment, Transporter Expression, and Resistance in Human Pancreatic Carcinoma Cells
|
journal
|
September 2010 |
|
Nucleoside Transport Inhibitors: Structure-Activity Relationships and Potential Therapeutic Applications
|
journal
|
February 1997 |
|
Nucleoside Transporter Proteins
|
journal
|
October 2009 |
|
Molecular predictors of gemcitabine response in pancreatic cancer
|
journal
|
January 2011 |
|
Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters
|
journal
|
July 2014 |